Thanks to the use of social safety nets, pharmaceutical companies are pursuing a policy of recovering their profits which passes, not through innovation and research, but through the reduction of the so-called fixed costs (personnel).
Dear colleagues, in this last period, which is already so difficult for our nation, we are appalled by the systematic cut in our sector of drug sales representatives and internal workers in the pharmaceutical industries.
Everyone is talking about what is happening in Sigma Tau, a company considered an Italian model of excellence both for the management of human resources and for the so-called industrial relations (see relationship between company and union) is in the throes of a homicidal madness that destroys company and workers. But that's not all, given what is happening in other companies such as Pfizer and lately in Astra Zeneca, which continue their dismantling work.
But as if that weren't enough, other dead and wounded are already on the horizon in our sector with the already announced reduction of the isf and workers of the Japanese Takeda in Europe and the USA and the French Sanofi Aventis.
In all this confusion, the Farmindustria press release of 01.24.2012 is like the icing on the cake. From it we learn that the same " strongly denounces the devastating effect on the country's pharmaceutical companies, which will derive from the provision included in the liberalization decree which in fact - diverting almost all medical prescriptions to generics only – cancels by law one of the most hi-tech sectors of our economy". "The measure – according to the latest circulating hypotheses – it would effectively force the doctor to indicate and the pharmacist to dispense only generic medicines, triggering an unacceptable distortion of competition to the detriment of the branded product.”
“ It is precisely now that pharmaceutical industrial companies could represent part of the solution to the country's problems, because they are the engine of growth. The consequences will be very serious for the employment of 65,000 employees ”
I don't want to sound polemical, but all these statements seem and try to confirm what is now known by many. Pharmaceutical companies have decided to "lighten" personnel now considered useless by downloading the costs on the whole of society. Thanks to the use of social safety nets, pharmaceutical companies are pursuing a policy of recovering their profits which passes, not through innovation and research, but through the reduction
